HER2-Positive Inflammatory Breast Cancer Challenges of Clinical Practices

HER2-positive inflammatory breast cancer (IBC) is associated with poor overall survival. Targeted therapies have led to improved outcomes. IBC is underrepresented in clinical trials due to its rareness. This case reports a 52-year-old woman diagnosed with IBC of 119x89mm, axillar node-positive, horm...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalhães, Denise, Rangel, Inês, Mesquita, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986522/
https://www.ncbi.nlm.nih.gov/pubmed/35399412
http://dx.doi.org/10.7759/cureus.22925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986522/
https://www.ncbi.nlm.nih.gov/pubmed/35399412
http://dx.doi.org/10.7759/cureus.22925

Ejemplares similares